BEKEMV DIN 02540509
Status: Cancelled Pre Market
Holder: AMGEN CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | ECULIZUMAB 10 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION; SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | L04AJ01 ECULIZUMAB |
|---|
| Original market date | |
|---|
| Current status date | 28-Apr-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Amgen Canada Inc — licence 100048, currently licensed, last inspection rating C (2023-03-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ECULIZUMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02547740 | EPYSQLI | SAMSUNG BIOEPIS CO., LTD | Solution | ECULIZUMAB 10 MG | Approved |
| 02322285 | SOLIRIS | ALEXION PHARMA GMBH | Solution | ECULIZUMAB 10 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37454 | 2026-04-22 | New Drug Submission (NDS) | |
Request a quote for BEKEMV
How to read a Canadian DIN record